Inbal Greenberg, Yacov Shacham, Maayan Konigstein, Shmuel Banai, Jeremy Ben-Shoshan
{"title":"经皮冠状动脉介入治疗患者早期与晚期急性肾损伤的比较。","authors":"Inbal Greenberg, Yacov Shacham, Maayan Konigstein, Shmuel Banai, Jeremy Ben-Shoshan","doi":"10.1159/000546496","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Acute kidney injury (AKI) frequently complicates ST-elevation myocardial infarction (STEMI) in patients undergoing primary percutaneous coronary intervention (PCI) and is associated with increased short- and long-term mortality. However, the impact of the AKI onset time following PCI on patient outcomes remains uncertain. This study aimed to investigate the timing of post-PCI AKI development and its prognostic significance in STEMI patients.</p><p><strong>Methods: </strong>This retrospective cohort study included 2,912 STEMI patients who underwent successful PCI upon admission. The timing of AKI was determined according to the Kidney Disease Improving Global Outcomes (KDIGO) criteria, using routine blood tests conducted during hospitalization. The primary endpoint was all-cause mortality.</p><p><strong>Results: </strong>Among 2,912 STEMI patients studied, 222 (7.6%) developed AKI. AKI was classified as early if it occurred within 1.5 days (n = 108, 48.6%) or late if it occurred after 1.5 days (n = 114, 51.4%). Early AKI was associated with a significantly higher incidence of cardiogenic shock at presentation, lower post-PCI left ventricular ejection fraction, and increased 30-day mortality compared to late AKI. In a multivariate Cox regression analysis, early AKI emerged as an independent predictor of long-term mortality (adjusted HR 1.8, 95% CI 1.1-2.8, p = 0.015). Additionally, multivariate logistic regression analysis identified cardiogenic shock as a significant predictor of early AKI (adjusted OR 2.3, 95% CI 1.1-4.9, p = 0.03).</p><p><strong>Conclusion: </strong>In STEMI patients, early AKI - compared to late AKI - is associated with higher short- and long-term mortality and occurs more frequently in those presenting with cardiogenic shock.</p>","PeriodicalId":9584,"journal":{"name":"Cardiorenal Medicine","volume":" ","pages":"526-534"},"PeriodicalIF":2.9000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12252143/pdf/","citationCount":"0","resultStr":"{\"title\":\"Early versus Late Acute Kidney Injury in Patients Undergoing Primary Percutaneous Coronary Intervention.\",\"authors\":\"Inbal Greenberg, Yacov Shacham, Maayan Konigstein, Shmuel Banai, Jeremy Ben-Shoshan\",\"doi\":\"10.1159/000546496\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Acute kidney injury (AKI) frequently complicates ST-elevation myocardial infarction (STEMI) in patients undergoing primary percutaneous coronary intervention (PCI) and is associated with increased short- and long-term mortality. However, the impact of the AKI onset time following PCI on patient outcomes remains uncertain. This study aimed to investigate the timing of post-PCI AKI development and its prognostic significance in STEMI patients.</p><p><strong>Methods: </strong>This retrospective cohort study included 2,912 STEMI patients who underwent successful PCI upon admission. The timing of AKI was determined according to the Kidney Disease Improving Global Outcomes (KDIGO) criteria, using routine blood tests conducted during hospitalization. The primary endpoint was all-cause mortality.</p><p><strong>Results: </strong>Among 2,912 STEMI patients studied, 222 (7.6%) developed AKI. AKI was classified as early if it occurred within 1.5 days (n = 108, 48.6%) or late if it occurred after 1.5 days (n = 114, 51.4%). Early AKI was associated with a significantly higher incidence of cardiogenic shock at presentation, lower post-PCI left ventricular ejection fraction, and increased 30-day mortality compared to late AKI. In a multivariate Cox regression analysis, early AKI emerged as an independent predictor of long-term mortality (adjusted HR 1.8, 95% CI 1.1-2.8, p = 0.015). Additionally, multivariate logistic regression analysis identified cardiogenic shock as a significant predictor of early AKI (adjusted OR 2.3, 95% CI 1.1-4.9, p = 0.03).</p><p><strong>Conclusion: </strong>In STEMI patients, early AKI - compared to late AKI - is associated with higher short- and long-term mortality and occurs more frequently in those presenting with cardiogenic shock.</p>\",\"PeriodicalId\":9584,\"journal\":{\"name\":\"Cardiorenal Medicine\",\"volume\":\" \",\"pages\":\"526-534\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12252143/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cardiorenal Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1159/000546496\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/5/17 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiorenal Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000546496","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/17 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
摘要
急性肾损伤(AKI)经常并发st段抬高型心肌梗死(STEMI)患者接受原发性经皮冠状动脉介入治疗(PCI),并与短期和长期死亡率增加相关。然而,PCI术后AKI发作时间对患者预后的影响仍不确定。本研究旨在探讨STEMI患者pci后AKI发生的时机及其预后意义。方法:本回顾性队列研究纳入了2,912例入院时成功行PCI的STEMI患者。AKI的时间根据肾脏疾病改善总体结局(KDIGO)标准确定,使用住院期间进行的常规血液检查。主要终点是全因死亡率。结果:在研究的2912例STEMI患者中,222例(7.6%)发生AKI。1.5天内发生的AKI为早期(n=108, 48.6%), 1.5天后发生的AKI为晚期(n=114, 51.4%)。与晚期AKI相比,早期AKI与出现时较高的心源性休克发生率、较低的pci后左室射血分数以及较高的30天死亡率相关。在多变量Cox回归分析中,早期AKI成为长期死亡率的独立预测因子(调整后危险度1.8,95% CI 1.1-2.8, p=0.015)。此外,多因素logistic回归分析发现心源性休克是早期AKI的重要预测因素(校正OR为2.3,95% CI为1.1-4.9,p=0.03)。结论:在STEMI患者中,与晚期aki相比,早期aki与更高的短期和长期死亡率相关,并且在出现心源性休克的患者中更常见。
Early versus Late Acute Kidney Injury in Patients Undergoing Primary Percutaneous Coronary Intervention.
Introduction: Acute kidney injury (AKI) frequently complicates ST-elevation myocardial infarction (STEMI) in patients undergoing primary percutaneous coronary intervention (PCI) and is associated with increased short- and long-term mortality. However, the impact of the AKI onset time following PCI on patient outcomes remains uncertain. This study aimed to investigate the timing of post-PCI AKI development and its prognostic significance in STEMI patients.
Methods: This retrospective cohort study included 2,912 STEMI patients who underwent successful PCI upon admission. The timing of AKI was determined according to the Kidney Disease Improving Global Outcomes (KDIGO) criteria, using routine blood tests conducted during hospitalization. The primary endpoint was all-cause mortality.
Results: Among 2,912 STEMI patients studied, 222 (7.6%) developed AKI. AKI was classified as early if it occurred within 1.5 days (n = 108, 48.6%) or late if it occurred after 1.5 days (n = 114, 51.4%). Early AKI was associated with a significantly higher incidence of cardiogenic shock at presentation, lower post-PCI left ventricular ejection fraction, and increased 30-day mortality compared to late AKI. In a multivariate Cox regression analysis, early AKI emerged as an independent predictor of long-term mortality (adjusted HR 1.8, 95% CI 1.1-2.8, p = 0.015). Additionally, multivariate logistic regression analysis identified cardiogenic shock as a significant predictor of early AKI (adjusted OR 2.3, 95% CI 1.1-4.9, p = 0.03).
Conclusion: In STEMI patients, early AKI - compared to late AKI - is associated with higher short- and long-term mortality and occurs more frequently in those presenting with cardiogenic shock.
期刊介绍:
The journal ''Cardiorenal Medicine'' explores the mechanisms by which obesity and other metabolic abnormalities promote the pathogenesis and progression of heart and kidney disease (cardiorenal metabolic syndrome). It provides an interdisciplinary platform for the advancement of research and clinical practice, focussing on translational issues.